Richard Tomasini
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.
Journal: The Journal of clinical investigation
Published: July 02, 2026
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage.
Journal: Science advances
Published: December 12, 2025
Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.
Journal: Cell communication and signaling : CCS
Published: September 12, 2023
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner.
Journal: PNAS nexus
Published: May 04, 2023
High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer.
Journal: The Journal of pathology
Published: April 11, 2023
Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking.
Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 06, 2023
CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness.
Journal: Science signaling
Published: August 02, 2022
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.
Journal: The EMBO journal
Published: December 29, 2021
Last Updated: 09/26/2026